Skip to content

Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention

Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01542957
Enrollment
128
Registered
2012-03-02
Start date
2011-11-30
Completion date
2015-05-31
Last updated
2017-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysthymic Disorder, Major Depressive Disorder

Keywords

Major Depressive Disorder, Dysthymic Disorder, Depression, Cognitive Behavior Therapy, Personal Construct Theory, Repertory Grid Technique, Cognitive Conflicts, Personal dilemmas

Brief summary

The purpose of this study is to determine the efficacy of a brief psychological intervention focused on the personal dilemmas identified for each depressive patient. For that, this intervention is combined to group cognitive therapy (an already proven efficacious format) and compared to cognitive individual therapy.

Detailed description

Depression is one of the more severe and serious health problems because of its morbidity, disabling effects and for its societal and economic burden. Despite the variety of existing pharmacological and psychological treatments most of the cases evolve with only partial remission, relapse and recurrence. Cognitive models made a significant contribution in the understanding of unipolar depression and its psychological treatment. Even though, success is only partial and many authors affirm the need to improve those models and also the treatment programs derived from them. One of the issues that requires further elaboration is the difficulty these patients experience in responding to treatment and in maintaining therapeutic gains across time without relapse or recurrence. Our research group has been working in the notion of cognitive conflict viewed as personal dilemma according to personal construct theory. The investigators use a novel method for identifying those conflicts using the repertory grid technique. Preliminary results with depressive patients show that more than 90% of them have one or more of those conflicts. This fact might explain the blockage and the difficult progress of these patients, especially the more severe and/or chronic. These results justify the need for specific interventions focused in the resolution of these internal conflicts. This study aims to empirically test the hypothesis that an intervention focused on the dilemma(s) specifically detected for each patient will contribute to enhance the efficacy of Cognitive-Behavioral Therapy for depression. A therapy manual for this approach will be tested using a randomized clinical trial by comparing the outcome of two treatment conditions: a CBT treatment package and another package combining cognitive-behavioral and dilemma-focused interventions. The investigators expect that this combined package will increase the efficacy of CBT, one of the more prestigious therapies for depression, this resulting in a significant contribution for its treatment.

Interventions

BEHAVIORALCombined Cognitive Behavioral and Dilemma-Focused Therapy

7 2-hour sessions of Group Cognitive Behavioral Therapy for Depression + 8 individual sessions of a Dilemma-Focused Intervention + 1 3-hour final group session. Manualized.

Cognitive Behavioral Therapy for Depression. Format: 7 2-hour sessions in group + 8 individual sessions + 1 3-hour final group session. Manualized.

Sponsors

National Distance Education University (UNED)
CollaboratorUNKNOWN
University of Minho
CollaboratorOTHER
University of Hertfordshire
CollaboratorOTHER
University of Bern
CollaboratorOTHER
University Ramon Llull
CollaboratorOTHER
Institut Trastorn Límit
CollaboratorUNKNOWN
Hospital de Mataró
CollaboratorOTHER
Fundació Institut de Recerca de l
CollaboratorUNKNOWN
Associació Centre de Salut Mental Nou Barris
CollaboratorUNKNOWN
Fundacion IMIM
CollaboratorOTHER
EAP Poble Sec
CollaboratorUNKNOWN
Associació Catalana de Terapies Cognitives
CollaboratorUNKNOWN
Sant Pere Claver Fundació Sanitaria
CollaboratorUNKNOWN
University of Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Meeting diagnostic criteria for Major Depressive Disorder (MDD) or Dysthymic Disorder (DD) according to the DSM-IV-TR (APA, 2002) criteria a assessed using SCID-I * A score above 19 on the BDI-II Questionnaire * Presenting at leat one cognitive conflict (implicative dilemma or dilemmatic construct) as assessed using the Repertory Grid Technique * Enough level of competence to communicate in Spanish or Catalan

Exclusion criteria

* Bipolar disorders * Psychotic symptoms * Substance abuse * Organic brain dysfunction * Mental retardation * Serious suicidal ideation * Receiving psychological treatment (unless it is suspended at the time of inclusion in the study itself, in agreement with the patient and the practitioner applying it) * Substantial visual, hearing or cognitive deficits

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-upEnd of therapy (16 weeks), 3 and 12-month follow-upTo assess change in severity of depressive symptoms. The Total score is reported, which is the sum of the ratings of all items and ranges from 0 to 63, with higher scores indicating more severity of depressive symptoms.

Secondary

MeasureTime frameDescription
Change From Baseline in Hamilton-Depression Rating Scale-17 ItemsEnd of therapy and 12-month follow-upThis clinician-administered measure was only applied to 78 patients at pre- and posttreatment. It measures severity of depressive symptoms. The Total score is reported, which is the sum of the ratings of all items and ranges from 0 to 54, with higher scores indicating more severity of depressive symptoms.
Change From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-upEnd of therapy, 3 and 12 month follow-upTo assess subjective well-being, symptoms or problems, life functioning, and risk. The Total score is reported, which is the sum of the ratings of all items divided by the number of items (34). The score and ranges from 0 to 4, with higher scores indicating more severity of psychological distress.

Countries

Spain

Participant flow

Participants by arm

ArmCount
Cognitive Behavioral + Dilemma Therapy
Combines Group Cognitive Behavioral Therapy with a Individual Dilemma-Focused Intervention Combined Cognitive Behavioral and Dilemma-Focused Therapy: 7 2-hour sessions of Group Cognitive Behavioral Therapy for Depression + 8 individual sessions of a Dilemma-Focused Intervention + 1 3-hour final group session. Manualized.
65
Cognitive Behavioral Therapy
Combined Group and Individual Cognitive Behavioral Therapy Cognitive Behavioral Therapy for Depression: Cognitive Behavioral Therapy for Depression. Format: 7 2-hour sessions in group + 8 individual sessions + 1 3-hour final group session. Manualized.
63
Total128

Baseline characteristics

CharacteristicCognitive Behavioral + Dilemma TherapyCognitive Behavioral TherapyTotal
Age, Continuous48.37 years
STANDARD_DEVIATION 11.22
50.06 years
STANDARD_DEVIATION 11.03
49.20 years
STANDARD_DEVIATION 11.19
Sex: Female, Male
Female
51 Participants48 Participants99 Participants
Sex: Female, Male
Male
14 Participants15 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Change From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-up

To assess change in severity of depressive symptoms. The Total score is reported, which is the sum of the ratings of all items and ranges from 0 to 63, with higher scores indicating more severity of depressive symptoms.

Time frame: End of therapy (16 weeks), 3 and 12-month follow-up

Population: The overall number of participants analyzed are those who completed the treatment but not all of them completed follow-up assessments at 3 and 12-month after the end of the therapy. In each row the number of those participants who completed the assessment are specified

ArmMeasureGroupValue (MEAN)Dispersion
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-upBaseline37.23 units on a scaleStandard Deviation 8.96
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-upAt the end of therapy change from baseline-17.62 units on a scaleStandard Deviation 12.05
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-up3-month follow-up change from baseline-15.42 units on a scaleStandard Deviation 13.16
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-up12-month follow-up change from baseline-19.51 units on a scaleStandard Deviation 13.17
Cognitive Behavioral TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-up12-month follow-up change from baseline-16.65 units on a scaleStandard Deviation 13.87
Cognitive Behavioral TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-upBaseline36.94 units on a scaleStandard Deviation 9.56
Cognitive Behavioral TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-up3-month follow-up change from baseline-15.60 units on a scaleStandard Deviation 15.56
Cognitive Behavioral TherapyChange From Baseline in Beck Depression Inventory-Second Edition (BDI-II) at the End of Therapy, 3 and 12-month Follow-upAt the end of therapy change from baseline-15.52 units on a scaleStandard Deviation 13.92
p-value: 0.695% CI: [-3.35, 1.43]Mixed Models Analysis
Secondary

Change From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-up

To assess subjective well-being, symptoms or problems, life functioning, and risk. The Total score is reported, which is the sum of the ratings of all items divided by the number of items (34). The score and ranges from 0 to 4, with higher scores indicating more severity of psychological distress.

Time frame: End of therapy, 3 and 12 month follow-up

Population: The overall number of participants analyzed are those who completed the treatment but not all of them completed follow-up assessments at 3 and 12-month after the end of the therapy. In each row the number of those participants who completed the assessment are specified

ArmMeasureGroupValue (MEAN)Dispersion
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-upBaseline2.17 units on a scaleStandard Deviation 0.5
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-upAt the end of therapy change from baselina-0.76 units on a scaleStandard Deviation 0.7
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-up3 month follow-up change from baseline-0.59 units on a scaleStandard Deviation 0.76
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-up12 month follow-up change from baseline-0.77 units on a scaleStandard Deviation 0.81
Cognitive Behavioral TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-up12 month follow-up change from baseline-0.58 units on a scaleStandard Deviation 0.86
Cognitive Behavioral TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-upBaseline2.08 units on a scaleStandard Deviation 0.56
Cognitive Behavioral TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-up3 month follow-up change from baseline-0.63 units on a scaleStandard Deviation 0.8
Cognitive Behavioral TherapyChange From Baseline in Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) at the End of Therapy, 3 and12 Month Follow-upAt the end of therapy change from baselina-0.67 units on a scaleStandard Deviation 0.75
p-value: 0.8495% CI: [-0.14, 0.12]Mixed Models Analysis
Secondary

Change From Baseline in Hamilton-Depression Rating Scale-17 Items

This clinician-administered measure was only applied to 78 patients at pre- and posttreatment. It measures severity of depressive symptoms. The Total score is reported, which is the sum of the ratings of all items and ranges from 0 to 54, with higher scores indicating more severity of depressive symptoms.

Time frame: End of therapy and 12-month follow-up

Population: The overall number of participants analyzed are those who completed the treatment but not all of them completed follow-up assessments at 3 and 12-month after the end of the therapy. In each row the number of those participants who completed the assessment are specified.

ArmMeasureGroupValue (MEAN)Dispersion
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Hamilton-Depression Rating Scale-17 ItemsBaseline18.93 units on a scaleStandard Deviation 6.96
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Hamilton-Depression Rating Scale-17 ItemsAt the end of therapy change from baseline-7.61 units on a scaleStandard Deviation 9.21
Cognitive Behavioral + Dilemma TherapyChange From Baseline in Hamilton-Depression Rating Scale-17 Items12 month follow-up change from baseline-5.32 units on a scaleStandard Deviation 9.56
Cognitive Behavioral TherapyChange From Baseline in Hamilton-Depression Rating Scale-17 ItemsBaseline20.05 units on a scaleStandard Deviation 6.09
Cognitive Behavioral TherapyChange From Baseline in Hamilton-Depression Rating Scale-17 ItemsAt the end of therapy change from baseline-8.84 units on a scaleStandard Deviation 8.28
Cognitive Behavioral TherapyChange From Baseline in Hamilton-Depression Rating Scale-17 Items12 month follow-up change from baseline-7.89 units on a scaleStandard Deviation 9.57
p-value: 0.2195% CI: [-0.71, 3.25]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026